Primary study · included by 1 review

Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease.

Katz 2003 · Katz J, Shenkman A, Stavropoulos F, et al. · Oral diseases · 2003

Included by

Oral Manifestations in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Non-Cochrane · prognostic · 2026 · cited as Katz 2003 · Table 1; forest plot Figure 2/3

Outcome this study informs	Pooled effect	Evidence	Certainty
Tongue alterations (coated, geographic, fissured tongue) Inflammatory bowel disease (single-arm prevalence) vs None (single-arm) · Not specified	Prevalence (proportion) 0.11 [0.04, 0.24]	5 studies · 248 participants	GRADE not reported
Taste changes Inflammatory bowel disease (single-arm prevalence) vs None (single-arm) · Not specified	Prevalence (proportion) 0.16 [0.05, 0.32]	6 studies · 492 participants	GRADE not reported
Oral ulcerations Inflammatory bowel disease (single-arm prevalence) vs None (single-arm) · Not specified	Prevalence (proportion) 0.20 [0.11, 0.33]	13 studies · 2599 participants	GRADE not reported
Dry mouth Inflammatory bowel disease (single-arm prevalence) vs None (single-arm) · Not specified	Prevalence (proportion) 0.32 [0.14, 0.59]	8 studies · 2240 participants	GRADE not reported
Halitosis Inflammatory bowel disease (single-arm prevalence) vs None (single-arm) · Not specified	Prevalence (proportion) 0.22 [0.07, 0.51]	9 studies · 3051 participants	GRADE not reported

1 including review in total.